Obesity, diabetes, metabolism and cardiovascular

ea0031p177 | Obesity, diabetes, metabolism and cardiovascular

Association of calcium-sensing receptor polymorphisms with vascular calcification and glucose homeostasis in renal transplant recipients

ea0031p178 | Obesity, diabetes, metabolism and cardiovascular

Testosterone stimulates cholesterol efflux and metabolism in human macrophages via liver X receptor

ea0031p179 | Obesity, diabetes, metabolism and cardiovascular

FGF21 action on human adipose tissue compromised by reduced βKlotho and FGFR1 expression in type 2 diabetes mellitus

ea0031p180 | Obesity, diabetes, metabolism and cardiovascular

A component of transcriptional PRC2 complex, enhancer of zest homology, modulates endothelial cell responses to hypoxia and post-ischemic angiogenesis in a mouse model of limb ischemia

ea0031p181 | Obesity, diabetes, metabolism and cardiovascular

The role of hepatic 11β-hydroxysteroid dehydrogenase type 1 in cholesterol homeostasis

ea0031p182 | Obesity, diabetes, metabolism and cardiovascular

Vitamin B12 and folate imbalance induces cholesterol synthesis and endoplasmic reticulum stress in human adipocytes

ea0031p183 | Obesity, diabetes, metabolism and cardiovascular

The effects of Syzygium aromaticum-derived oleanolic acid on reactive oxygen species in the heart, liver and kidney of STZ-induced diabetic rats

ea0031p184 | Obesity, diabetes, metabolism and cardiovascular

Effects of vitamin D supplementation on blood pressure, glucocorticoids and cardiovascular risk markers in healthy subjects

ea0031p185 | Obesity, diabetes, metabolism and cardiovascular

Knockdown of brain 11β-HSD1 does not lower body weight or improve insulin sensitivity

ea0031p186 | Obesity, diabetes, metabolism and cardiovascular

C-type natriuretic peptide down regulates interferon γ mediated pro-inflammatory gene expression in human endothelium

ea0031p187 | Obesity, diabetes, metabolism and cardiovascular

Acute effects of co-infusion of peptide YY (3–36) and glucagon-like peptide-1 on insulin secretion and insulin sensitivity

ea0031p188 | Obesity, diabetes, metabolism and cardiovascular

Human abdominal subcutaneous adipocytes as an active source of LpPLA2, influenced by fat depot and metabolic state, with LpPLA2 converting LDL into more potent atherogenic Ox-LDL, in vitro

ea0031p189 | Obesity, diabetes, metabolism and cardiovascular

The role of glucocorticoid metabolism in bile acid homeostasis

ea0031p190 | Obesity, diabetes, metabolism and cardiovascular

Testosterone differentially regulates lipid and glucose metabolism in visceral and subcutaneous fat in the testicular feminised mouse

ea0031p191 | Obesity, diabetes, metabolism and cardiovascular

Novel inositol pyrophosphate and insulin sensitivity in response to muscle contraction in glucose intolerant humans

ea0031p192 | Obesity, diabetes, metabolism and cardiovascular

Augurin stimulates food intake in male Wistar rats

ea0031p193 | Obesity, diabetes, metabolism and cardiovascular

Abstract unavailable

ea0031p194 | Obesity, diabetes, metabolism and cardiovascular

Intracellular delivery of therapeutic siRNA via an antennapedia-double stranded RNA binding domain fusion protein as a novel strategy for PTP1B translation attenuation in type 2 diabetes

ea0031p195 | Obesity, diabetes, metabolism and cardiovascular

Replication of genome wide association-validated loci for type 2 diabetes mellitus in the Saudi Arabian population

ea0031p196 | Obesity, diabetes, metabolism and cardiovascular

Cellular consequences for insulin signal transduction of the naturally occurring AKT2 p.Glu17Lys mutation

ea0031p197 | Obesity, diabetes, metabolism and cardiovascular

DPPIV and macronutrients regulate the expression of PYY3–36 in human gut epithelial cells

ea0031p198 | Obesity, diabetes, metabolism and cardiovascular

Inflammatory markers in diabetic foot and impact of vitamin D deficiency

ea0031p199 | Obesity, diabetes, metabolism and cardiovascular

The possible involvement of the receptor for advanced glycation end products in vascular senescence in diabetes

ea0031p200 | Obesity, diabetes, metabolism and cardiovascular

Effects of Syzygium aromaticum-derived oleanolic acid administration on postprandial glucose concentration and key intestinal carbohydrate hydrolyzing enzymes of streptozotocin-induced diabetic rats

ea0031p201 | Obesity, diabetes, metabolism and cardiovascular

Unfolded protein response pathway, IRE1α-XBP1 is altered during adipogenesis in obese human adipocytes

ea0031p202 | Obesity, diabetes, metabolism and cardiovascular

Vitamin D and insulin resistance: no association in healthy overweight people at high risk of cardiovascular disease

ea0031p203 | Obesity, diabetes, metabolism and cardiovascular

Evaluation of efficacy of transdermal delivery of chloroquine on Plasmodium berghei-infected male Sprague–Dawley rats and effects on blood glucose and renal electrolyte handling

ea0031p204 | Obesity, diabetes, metabolism and cardiovascular

Altered mitochondrial dynamics in obesity: redressing the balance through bariatric surgery?

ea0031p205 | Obesity, diabetes, metabolism and cardiovascular

Irisin as a central regulator in energy homeostasis?

ea0031p206 | Obesity, diabetes, metabolism and cardiovascular

Ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes

ea0031p207 | Obesity, diabetes, metabolism and cardiovascular

Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity

ea0031p208 | Obesity, diabetes, metabolism and cardiovascular

Leptin in serum and vitreous humor, and retinal ob mRNA, in human diabetes

ea0031p209 | Obesity, diabetes, metabolism and cardiovascular

The endocrine and metabolic characteristics of a large Bardet–Biedl syndrome clinic population

ea0031p210 | Obesity, diabetes, metabolism and cardiovascular

Maternal B12 insufficiency predicts neonate's metabolic risk factors

ea0031p211 | Obesity, diabetes, metabolism and cardiovascular

The use of GLP-1 receptor agonists to manage unwanted weight gain in patients with ‘hypothalamic’ obesity secondary to structural pituitary pathology

ea0031p212 | Obesity, diabetes, metabolism and cardiovascular

The public distress domain of quality of life correlates directly and independently with BMI in pre-operative morbidly obese patients awaiting metabolic surgery

ea0031p213 | Obesity, diabetes, metabolism and cardiovascular

Pregestational BMI predicts neonatal hypoglycemia in women with gestational diabetes

ea0031p214 | Obesity, diabetes, metabolism and cardiovascular

Effectiveness of bariatric surgery in women with and without polycystic ovarian syndrome

ea0031p215 | Obesity, diabetes, metabolism and cardiovascular

Octreotide therapy of chronic urticaria and angioedema after gastric bypass procedure

ea0031p216 | Obesity, diabetes, metabolism and cardiovascular

Prevalence of vitamin D insufficiency in severely obese patients seeking bariatric surgery

ea0031p217 | Obesity, diabetes, metabolism and cardiovascular

Appetite regulation during a 6-month military tour to Afghanistan

ea0031p218 | Obesity, diabetes, metabolism and cardiovascular

Weight loss after bariatric surgery in women of childbearing age

ea0031p219 | Obesity, diabetes, metabolism and cardiovascular

Eating more quickly heightens overall systemic exposure to glucose and NEFA in the post-prandial phase, irrespective of energy expenditure in obese women

ea0031p220 | Obesity, diabetes, metabolism and cardiovascular

Hepatic 11β-hydroxysteroid dehydrogenase type 1 is elevated following weight loss secondary to bariatric surgery

ea0031p221 | Obesity, diabetes, metabolism and cardiovascular

Brown adipose tissue identification in an adult human using IDEAL MRI

ea0031p222 | Obesity, diabetes, metabolism and cardiovascular

Vitamin D supplementation as influenced by diabetic therapies

ea0031p223 | Obesity, diabetes, metabolism and cardiovascular

Association of the incidence of type 1 diabetes with markers of infection and antibiotic susceptibility at country level

ea0031p224 | Obesity, diabetes, metabolism and cardiovascular

A pilot study of 25-hydroxy vitamin D level in type 2 diabetes mellitus with diabetic retinopathy

ea0031p225 | Obesity, diabetes, metabolism and cardiovascular

Non-alcoholic fatty liver disease in patients attending the National Severe Insulin Resistance Service

ea0031p226 | Obesity, diabetes, metabolism and cardiovascular

A study of serum osteocalcin level in women with gestational diabetes mellitus

ea0031p227 | Obesity, diabetes, metabolism and cardiovascular

Short term calorie restriction: effects on endocrine markers of nutritional status

ea0031p228 | Obesity, diabetes, metabolism and cardiovascular

The development of a structured education programme to improve cardiovascular risk in women with polycystic ovary syndrome (SUCCESS Study)

ea0031p229 | Obesity, diabetes, metabolism and cardiovascular

Hypogonadism in males with type 2 diabetes mellitus

ea0031p230 | Obesity, diabetes, metabolism and cardiovascular

Obesity-related hypogonadotrophic hypogonadism: recovery of normal pituitary–gonadal axis function following bariatric surgery

ea0031p231 | Obesity, diabetes, metabolism and cardiovascular

Risk assessment of adult residents in ile-ife, South-Western Nigeria for type 2 diabetes mellitus

ea0031p232 | Obesity, diabetes, metabolism and cardiovascular

Adrenal insufficiency post bariatric surgery

ea0031p233 | Obesity, diabetes, metabolism and cardiovascular

Pregnancy outcome in a patient with lipodystrophy and type 2 diabetes

ea0031p234 | Obesity, diabetes, metabolism and cardiovascular

Impaired iron status in severely obese bariatric surgery candidates is multifactorial

ea0031p235 | Obesity, diabetes, metabolism and cardiovascular

What lies beneath: a case of spontaneous hypoglycaemia or glucose transporter type 1 defect disguised as chronic fatigue?

ea0031p236 | Obesity, diabetes, metabolism and cardiovascular

Improvement in testosterone post bariatric surgery

ea0031p237 | Obesity, diabetes, metabolism and cardiovascular

Prevalence and associated risks for metabolic syndrome in nigerians with type 2 diabetes mellitus

ea0031p238 | Obesity, diabetes, metabolism and cardiovascular

Ethnic specific anthropometric values have been used by the International Diabetes Federation to aid in the diagnosis of the metabolic syndrome: no such values are available for Sub-Saharan Africa including Nigeria

ea0031p239 | Obesity, diabetes, metabolism and cardiovascular

Preoperative characteristics of morbidly obese patients who achieved at least 50% excess weight loss post-metabolic Surgery

ea0031p240 | Obesity, diabetes, metabolism and cardiovascular

Society for Endocrinology BES 2013

Abstract unavailable

BiosciAbstracts